Pulmonology
A section of Journal of Clinical Medicine (ISSN 2077-0383).
Section Information
We take our respiratory health and breathing for granted. The human lung is a vital organ that is vulnerable to outside insults and injuries. Nothing else matters when you cannot breathe. Pulmonary diseases are a leading cause of morbidity, mortality and disability in the world. Our lungs are frequently exposed to numerous noxious agents present in the air we breathe, such as particulate matter, biomass fuel, tobacco cigarette smoking, aerosols from electronic cigarettes, heat-not-burn products (IQOS), chemicals, pesticides and respiratory pathogens. If we have a closer look at the numbers, then at least 2 billion people are exposed globally to the toxic smoke produced by the combustion of biomass fuel, inefficiently burned in poorly ventilated indoor stoves or fireplaces used for cooking or warming. One billion people inhale polluted outdoor air, and another billion are exposed primarily or secondarily to tobacco smoke, with the numbers on a steep upward trajectory. In December 2019, we saw the start of a new virus pandemic of a severe pulmonary disease, now called coronavirus disease 2019, abbreviated as “COVID-19”. The cause of COVID-19 infections is attributed to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). As this pandemic continues to ultimately grasp the year 2020, it is imperative that respiratory health must be a top priority. There is an expeditious need to bolster research and long-term commitment to respiratory health. To promote respiratory research and dissemination, we sincerely welcome your submissions to Journal of Clinical Medicine. We welcome all submissions enhancing the understanding of pulmonary diseases and look forward to receiving your manuscripts.
Subject Areas
- COPD
- Asthma
- Pulmonary infections
- COVID-19
- Tuberculosis
- Lung cancer
- Bronchiectasis
- Cystic fibrosis
- Interstitial lung disease
- Pulmonary hypertension
- Sleep Apnea
- Rare lung diseases
- Asbestosis
- Silicosis
- Sarcoidosis
- Electronic nicotine delivery systems
- Tobacco smoking
- Air pollution
- Biomass fuel
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Non-invasive Respiratory Support: How to Get It Right in Clinical Medicine (Deadline: 22 February 2023)
- Clinical Management of Respiratory Tract Infection (Deadline: 25 February 2023)
- Acute Respiratory Distress Syndrome: Novel Therapeutic Approaches and Strategy (Deadline: 15 March 2023)
- Clinical Advances in Allergy and Asthma: Issues, Strategies, and Future Directions (Deadline: 22 March 2023)
- New Insights into Acute Respiratory Distress Syndrome (Deadline: 20 April 2023)
- Target and Im-Oncology Therapeutic Approaches for Lung Cancer (Deadline: 25 April 2023)
- Advances in Asthma (Deadline: 25 April 2023)
- Management of Lung Transplantation in the COVID-19 Era (Deadline: 25 April 2023)
- Clinical Application of Biological Therapies in Severe Asthma (Deadline: 10 May 2023)
- Clinical and Physiological Consequences of Hypoxia/Hypoxemia in Healthy Subjects and Patients (Deadline: 10 May 2023)
- Clinical Advances in Cystic Fibrosis (Deadline: 25 May 2023)
- Extracorporeal Membrane Oxygenation (ECMO): Current Progress and Clinical Challenges (Deadline: 25 May 2023)
- Clinical Advances in Chronic Obstructive Pulmonary Disease and Its Complications (Deadline: 25 May 2023)
- High Flow Nasal Cannula in Acute and Chronic Settings: Trends of Use and Outcomes (Deadline: 25 May 2023)
- Pulmonary Hypertension: Pathophysiology, Innovative Exploration and Therapies (Deadline: 25 May 2023)
- Congenital Diaphragmatic Hernia: What Is New in the Clinical Research? (Deadline: 30 May 2023)
- An Update on the Diagnostic, Predictive and Prognostic Biomarkers of Respiratory Diseases (Deadline: 31 May 2023)
- Prevention and Biomarkers of Respiratory Diseases (Deadline: 31 May 2023)
- Clinical Perspectives of Pulmonary Rehabilitation (Deadline: 10 June 2023)
- Pulmonary Arterial Hypertension: Old Drugs and New Treatment Strategies (Deadline: 15 June 2023)
- The Role of Interventional Pulmonology in Respiratory Diseases: From Diagnosis to Treatment (Deadline: 20 June 2023)
- Pediatric Sleep-Disordered Breathing and Long-Term Complications: Clinical and Health Implications (Deadline: 25 June 2023)
- Acute Respiratory Failure: New Perspectives and Current Clinical Challenges (Deadline: 25 July 2023)
- Liquid Biopsy for Lung Cancer (Deadline: 25 July 2023)
- Prevention, Diagnosis and Treatments of Early-Stage NSCLC: New Frontiers and Future Prospective (Deadline: 25 July 2023)
- Advances in Thoracic Oncology Multidisciplinary Care (Deadline: 15 August 2023)
- Clinical Advances in Bronchitis (Deadline: 20 August 2023)
- Thoracic Surgery: Current and Future Strategies (Deadline: 25 August 2023)
- Living with Chronic Obstructive Pulmonary Disease: Part II (Deadline: 31 August 2023)
- Current Perspectives on the Treatment of Obstructive Sleep Apnea - Part II (Deadline: 15 September 2023)
- Lung Cancer Surgery: Where Are We Now? (Deadline: 15 September 2023)
- Novel Insight into Cough: Seed of Respiratory Disease with a Focus on Children (Deadline: 20 September 2023)
- Clinical Guidelines for Pulmonary Medicine: Quality of Diagnostic and Therapeutic Management (Deadline: 20 September 2023)
- Cystic Fibrosis: The New Face of the Disease (Deadline: 20 September 2023)
- Current Status and Future Trends in Lung Transplantation (Deadline: 25 September 2023)
- Advances in Pulmonary Rehabilitation (Deadline: 20 October 2023)
- Pulmonary Hypertension: Updates in Diagnosis and Management (Deadline: 20 October 2023)
- Obstructive Sleep Apnea(OSA): What Can We Do Now? (Deadline: 25 October 2023)
- Current Challenges and Advances in Pleural Disease (Deadline: 25 October 2023)
- Advances in the Diagnosis and Treatment of Pulmonary Sarcoidosis (Deadline: 15 November 2023)
Topical Collections
Following topical collections within this section are currently open for submissions: